Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
42
CE Quote, Financials, Valuation and Earnings
Last price:
$58.53
Seasonality move
:
0.04%
Day range:
$55.39 - $58.09
52-week range:
$36.29 - $147.86
Dividend yield:
2.57%
P/E ratio:
7.03x
P/S ratio:
0.62x
P/B ratio:
1.20x
Volume:
1.4M
Avg. volume:
1.6M
1-year change:
-61.41%
Market cap:
$6.2B
Revenue:
$10.3B
EPS (TTM):
-$15.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | $8.5B | $9.7B | $10.9B | $10.3B | |
| Revenue Growth (YoY) | -10.2% | 50.96% | 13.31% | 13.1% | -6.03% | |
| Cost of Revenues | $4.4B | $5.9B | $7.3B | $8.3B | $7.9B | |
| Gross Profit | $1.3B | $2.7B | $2.4B | $2.6B | $2.4B | |
| Gross Profit Margin | 22.87% | 31.42% | 24.61% | 23.79% | 22.92% | |
| R&D Expenses | $74M | $86M | $112M | $146M | $130M | |
| Selling, General & Admin | $482M | $633M | $824M | $1.1B | $1B | |
| Other Inc / (Exp) | $1.6B | $402M | $375M | $653M | -$1.4B | |
| Operating Expenses | $578M | $744M | $998M | $1.4B | $1.3B | |
| Operating Income | $715M | $1.9B | $1.4B | $1.2B | $1B | |
| Net Interest Expenses | $103M | $92M | $336M | $688M | $643M | |
| EBT. Incl. Unusual Items | $2.3B | $2.2B | $1.4B | $1.2B | -$996M | |
| Earnings of Discontinued Ops. | -$12M | -$22M | -$8M | -$9M | -$8M | |
| Income Tax Expense | $247M | $330M | -$489M | -$790M | $510M | |
| Net Income to Company | $2B | $1.9B | $1.9B | $2B | -$1.5B | |
| Minority Interest in Earnings | -$7M | -$6M | -$8M | -$4M | -$8M | |
| Net Income to Common Excl Extra Items | $2B | $1.9B | $1.9B | $2B | -$1.5B | |
| Basic EPS (Cont. Ops) | $16.85 | $16.99 | $17.48 | $18.01 | -$13.93 | |
| Diluted EPS (Cont. Ops) | $16.75 | $16.86 | $17.34 | $17.92 | -$13.93 | |
| Weighted Average Basic Share | $117.8M | $111.2M | $108.4M | $108.8M | $109.3M | |
| Weighted Average Diluted Share | $118.5M | $112.1M | $109.2M | $109.4M | $109.3M | |
| EBITDA | $2.7B | $2.7B | $2.3B | $2.6B | $503M | |
| EBIT | $2.4B | $2.3B | $1.8B | $1.9B | -$320M | |
| Revenue (Reported) | $5.7B | $8.5B | $9.7B | $10.9B | $10.3B | |
| Operating Income (Reported) | $715M | $1.9B | $1.4B | $1.2B | $1B | |
| Operating Income (Adjusted) | $2.4B | $2.3B | $1.8B | $1.9B | -$320M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.5B | $2.9B | $2.6B | $2.4B | |
| Revenue Growth (YoY) | 23.15% | 41.16% | 12.41% | -8.48% | -8.5% | |
| Cost of Revenues | $1.3B | $1.8B | $2.2B | $2.1B | $1.9B | |
| Gross Profit | $485M | $745M | $631M | $554M | $476M | |
| Gross Profit Margin | 26.97% | 29.35% | 22.12% | 21.22% | 19.93% | |
| R&D Expenses | $20M | $24M | $42M | $34M | $31M | |
| Selling, General & Admin | $137M | $174M | $285M | $265M | $230M | |
| Other Inc / (Exp) | $111M | $114M | $32M | $99M | $20M | |
| Operating Expenses | $163M | $209M | $368M | $340M | $301M | |
| Operating Income | $322M | $536M | $263M | $214M | $175M | |
| Net Interest Expenses | $24M | $34M | $174M | $156M | $198M | |
| EBT. Incl. Unusual Items | $409M | $616M | $121M | $157M | -$3M | |
| Earnings of Discontinued Ops. | -$1M | -- | -$3M | -- | -$5M | |
| Income Tax Expense | $85M | $112M | $25M | $33M | $9M | |
| Net Income to Company | $323M | $504M | $93M | $124M | -$17M | |
| Minority Interest in Earnings | -$1M | -$2M | -$2M | -$3M | -$4M | |
| Net Income to Common Excl Extra Items | $322M | $502M | $91M | $121M | -$21M | |
| Basic EPS (Cont. Ops) | $2.84 | $4.64 | $0.84 | $1.11 | -$0.19 | |
| Diluted EPS (Cont. Ops) | $2.82 | $4.61 | $0.83 | $1.10 | -$0.19 | |
| Weighted Average Basic Share | $113.5M | $108.2M | $108.6M | $109.1M | $109.4M | |
| Weighted Average Diluted Share | $114M | $108.9M | $109.2M | $109.5M | $109.4M | |
| EBITDA | $525M | $757M | $481M | $553M | $358M | |
| EBIT | $434M | $651M | $303M | $326M | $167M | |
| Revenue (Reported) | $1.8B | $2.5B | $2.9B | $2.6B | $2.4B | |
| Operating Income (Reported) | $322M | $536M | $263M | $214M | $175M | |
| Operating Income (Adjusted) | $434M | $651M | $303M | $326M | $167M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | $9.3B | $10B | $10.7B | $10.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.6B | $6.3B | $7.7B | $8.2B | $7.8B | |
| Gross Profit | $1.4B | $2.9B | $2.3B | $2.5B | $2.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $77M | $90M | $130M | $138M | $127M | |
| Selling, General & Admin | $494M | $670M | $935M | $1.1B | $993M | |
| Other Inc / (Exp) | $1.6B | $405M | $293M | $722M | -$1.5B | |
| Operating Expenses | $594M | $790M | $1.2B | $1.4B | $1.3B | |
| Operating Income | $836M | $2.2B | $1.1B | $1.2B | $1B | |
| Net Interest Expenses | $101M | $102M | $476M | $670M | $685M | |
| EBT. Incl. Unusual Items | $2.4B | $2.5B | $926M | $1.2B | -$1.2B | |
| Earnings of Discontinued Ops. | -$6M | -$21M | -$11M | -$6M | -$13M | |
| Income Tax Expense | $267M | $357M | -$576M | -$782M | $486M | |
| Net Income to Company | $2.1B | $2.1B | $1.5B | $2B | -$1.7B | |
| Minority Interest in Earnings | -$6M | -$7M | -$8M | -$5M | -$9M | |
| Net Income to Common Excl Extra Items | $2.1B | $2.1B | $1.5B | $2B | -$1.7B | |
| Basic EPS (Cont. Ops) | $18.05 | $18.83 | $13.68 | $18.27 | -$15.21 | |
| Diluted EPS (Cont. Ops) | $17.97 | $18.73 | $13.58 | $18.17 | -$15.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.8B | $2.9B | $2B | $2.7B | $308M | |
| EBIT | $2.5B | $2.6B | $1.5B | $1.9B | -$479M | |
| Revenue (Reported) | $6B | $9.3B | $10B | $10.7B | $10.1B | |
| Operating Income (Reported) | $836M | $2.2B | $1.1B | $1.2B | $1B | |
| Operating Income (Adjusted) | $2.5B | $2.6B | $1.5B | $1.9B | -$479M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.5B | $2.9B | $2.6B | $2.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.3B | $1.8B | $2.2B | $2.1B | $1.9B | |
| Gross Profit | $485M | $745M | $631M | $554M | $476M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $20M | $24M | $42M | $34M | $31M | |
| Selling, General & Admin | $137M | $174M | $285M | $265M | $230M | |
| Other Inc / (Exp) | $111M | $114M | $32M | $99M | $20M | |
| Operating Expenses | $163M | $209M | $368M | $340M | $301M | |
| Operating Income | $322M | $536M | $263M | $214M | $175M | |
| Net Interest Expenses | $24M | $34M | $174M | $156M | $198M | |
| EBT. Incl. Unusual Items | $409M | $616M | $121M | $157M | -$3M | |
| Earnings of Discontinued Ops. | -$1M | -- | -$3M | -- | -$5M | |
| Income Tax Expense | $85M | $112M | $25M | $33M | $9M | |
| Net Income to Company | $323M | $504M | $93M | $124M | -$17M | |
| Minority Interest in Earnings | -$1M | -$2M | -$2M | -$3M | -$4M | |
| Net Income to Common Excl Extra Items | $322M | $502M | $91M | $121M | -$21M | |
| Basic EPS (Cont. Ops) | $2.84 | $4.64 | $0.84 | $1.11 | -$0.19 | |
| Diluted EPS (Cont. Ops) | $2.82 | $4.61 | $0.83 | $1.10 | -$0.19 | |
| Weighted Average Basic Share | $113.5M | $108.2M | $108.6M | $109.1M | $109.4M | |
| Weighted Average Diluted Share | $114M | $108.9M | $109.2M | $109.5M | $109.4M | |
| EBITDA | $525M | $757M | $481M | $553M | $358M | |
| EBIT | $434M | $651M | $303M | $326M | $167M | |
| Revenue (Reported) | $1.8B | $2.5B | $2.9B | $2.6B | $2.4B | |
| Operating Income (Reported) | $322M | $536M | $263M | $214M | $175M | |
| Operating Income (Adjusted) | $434M | $651M | $303M | $326M | $167M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $955M | $536M | $1.5B | $1.8B | $962M | |
| Short Term Investments | $533M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $792M | $1.2B | $1.4B | $1.2B | $1.1B | |
| Inventory | $978M | $1.5B | $2.8B | $2.4B | $2.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $55M | $80M | $241M | $272M | $285M | |
| Total Current Assets | $3.8B | $3.8B | $6.6B | $6.2B | $5.1B | |
| Property Plant And Equipment | $4.2B | $4.4B | $6B | $6B | $5.7B | |
| Long-Term Investments | $820M | $823M | $1.1B | $1.2B | $1.2B | |
| Goodwill | $1.2B | $1.4B | $7.1B | $7B | $5.4B | |
| Other Intangibles | $319M | $735M | $4.1B | $4B | $3.6B | |
| Other Long-Term Assets | $411M | $521M | $547M | $524M | $555M | |
| Total Assets | $10.9B | $12B | $26.3B | $26.6B | $22.9B | |
| Accounts Payable | $797M | $1.2B | $1.5B | $1.5B | $1.2B | |
| Accrued Expenses | $150M | $165M | $416M | $421M | $388M | |
| Current Portion Of Long-Term Debt | $496M | $591M | $1B | $1.2B | $1.4B | |
| Current Portion Of Capital Lease Obligations | $36M | $37M | $83M | $89M | $79M | |
| Other Current Liabilities | $253M | $122M | $468M | $395M | $386M | |
| Total Current Liabilities | $2B | $2.5B | $4.1B | $4.1B | $3.9B | |
| Long-Term Debt | $3.2B | $3.2B | $13.4B | $12.3B | $11.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7B | $7.4B | $20.2B | $19B | $17.2B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$328M | -$329M | -$518M | -$744M | -$848M | |
| Common Equity | $3.5B | $4.2B | $5.6B | $7.1B | $5.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $369M | $348M | $468M | $461M | $434M | |
| Total Equity | $3.9B | $4.5B | $6.1B | $7.6B | $5.6B | |
| Total Liabilities and Equity | $10.9B | $12B | $26.3B | $26.6B | $22.9B | |
| Cash and Short Terms | $1.5B | $536M | $1.5B | $1.8B | $962M | |
| Total Debt | $3.7B | $4B | $14.7B | $13.7B | $12.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $791M | $605M | $1.2B | $1.5B | $951M | |
| Short Term Investments | $331M | $9M | -- | -- | -- | |
| Accounts Receivable, Net | $959M | $1.4B | $1.6B | $1.3B | $1.2B | |
| Inventory | $1B | $1.5B | $2.7B | $2.4B | $2.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $53M | $124M | $219M | $283M | $278M | |
| Total Current Assets | $3.7B | $4.2B | $6.4B | $5.9B | $5.4B | |
| Property Plant And Equipment | $4.1B | $4.5B | $6B | $5.9B | $5.6B | |
| Long-Term Investments | $796M | $847M | $1B | $1.2B | $1.2B | |
| Goodwill | $1.1B | $1.4B | $7.1B | $6.9B | $5.4B | |
| Other Intangibles | $308M | $715M | $4.1B | $3.9B | $3.7B | |
| Other Long-Term Assets | $456M | $569M | $553M | $537M | $543M | |
| Total Assets | $10.8B | $12.4B | $26.1B | $26B | $23.2B | |
| Accounts Payable | $906M | $1.2B | $1.4B | $1.4B | $1.3B | |
| Accrued Expenses | $123M | $116M | $278M | $327M | $276M | |
| Current Portion Of Long-Term Debt | $497M | $560M | $1.2B | $2.4B | $345M | |
| Current Portion Of Capital Lease Obligations | $36M | $44M | $110M | $86M | $78M | |
| Other Current Liabilities | $124M | $135M | $419M | $364M | $358M | |
| Total Current Liabilities | $1.9B | $2.6B | $3.9B | $4.9B | $2.8B | |
| Long-Term Debt | $3.1B | $3.1B | $13.4B | $11B | $12.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.8B | $7.5B | $20B | $18.5B | $17.6B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$302M | -$333M | -$502M | -$797M | -$817M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $365M | $346M | $469M | $460M | $429M | |
| Total Equity | $3.9B | $5B | $6.1B | $7.5B | $5.6B | |
| Total Liabilities and Equity | $10.8B | $12.4B | $26.1B | $26B | $23.2B | |
| Cash and Short Terms | $1.1B | $614M | $1.2B | $1.5B | $951M | |
| Total Debt | $3.6B | $4B | $14.8B | $13.5B | $12.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $1.9B | $1.9B | $2B | -$1.5B | |
| Depreciation & Amoritzation | $356M | $378M | $478M | $739M | $823M | |
| Stock-Based Compensation | $28M | $95M | $60M | $40M | $32M | |
| Change in Accounts Receivable | $141M | -$396M | $218M | $105M | $92M | |
| Change in Inventories | $124M | -$367M | -$253M | $398M | $11M | |
| Cash From Operations | $1.3B | $1.8B | $1.8B | $1.9B | $966M | |
| Capital Expenditures | $364M | $467M | $543M | $568M | $435M | |
| Cash Acquisitions | $1.5B | -$1.1B | -$10.5B | $532M | -- | |
| Cash From Investing | $592M | -$1.1B | -$11.1B | -$134M | -$470M | |
| Dividends Paid (Ex Special Dividend) | -$293M | -$304M | -$297M | -$305M | -$307M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $311M | $1.2B | $11.3B | $3.5B | $503M | |
| Long-Term Debt Repaid | -$783M | -$792M | -$526M | -$4.5B | -$1.5B | |
| Repurchase of Common Stock | -$650M | -$1B | -$17M | -- | -- | |
| Other Financing Activities | -$56M | -$142M | -$175M | -$63M | -$59M | |
| Cash From Financing | -$1.5B | -$1B | $10.3B | -$1.5B | -$1.3B | |
| Beginning Cash (CF) | $463M | $955M | $536M | $1.5B | $1.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $464M | -$404M | $968M | $309M | -$817M | |
| Ending Cash (CF) | $955M | $536M | $1.5B | $1.8B | $962M | |
| Levered Free Cash Flow | $979M | $1.3B | $1.3B | $1.3B | $531M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $323M | $504M | $93M | $124M | -$17M | |
| Depreciation & Amoritzation | $91M | $106M | $178M | $227M | $191M | |
| Stock-Based Compensation | $12M | $15M | $14M | $10M | $5M | |
| Change in Accounts Receivable | -$184M | -$240M | -$216M | -$55M | -$99M | |
| Change in Inventories | -$62M | -$32M | $45M | -$19M | $14M | |
| Cash From Operations | $116M | $316M | -$96M | $101M | $37M | |
| Capital Expenditures | $92M | $137M | $164M | $137M | $102M | |
| Cash Acquisitions | -- | -- | $9M | -- | $6M | |
| Cash From Investing | $98M | -$149M | -$178M | -$151M | -$98M | |
| Dividends Paid (Ex Special Dividend) | -$78M | -$73M | -$76M | -$77M | -$3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $74M | $338M | $267M | $3.3B | |
| Long-Term Debt Repaid | -$7M | -$7M | -$307M | -$424M | -$3.2B | |
| Repurchase of Common Stock | -$267M | -$17M | -- | -- | -- | |
| Other Financing Activities | -$21M | -$72M | -$24M | -$26M | -$78M | |
| Cash From Financing | -$371M | -$95M | -$69M | -$259M | $45M | |
| Beginning Cash (CF) | $955M | $536M | $1.5B | $1.8B | $962M | |
| Foreign Exchange Rate Adjustment | -$7M | -$3M | $2M | -$13M | $5M | |
| Additions / Reductions | -$157M | $72M | -$343M | -$309M | -$16M | |
| Ending Cash (CF) | $791M | $605M | $1.2B | $1.5B | $951M | |
| Levered Free Cash Flow | $24M | $179M | -$260M | -$36M | -$65M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1B | $2.1B | $1.5B | $2B | -$1.7B | |
| Depreciation & Amoritzation | $361M | $393M | $550M | $788M | $787M | |
| Stock-Based Compensation | $30M | $98M | $59M | $36M | $27M | |
| Change in Accounts Receivable | -$32M | -$452M | $242M | $266M | $48M | |
| Change in Inventories | $73M | -$337M | -$176M | $334M | $44M | |
| Cash From Operations | $1.2B | $2B | $1.4B | $2.1B | $902M | |
| Capital Expenditures | $337M | $512M | $570M | $541M | $400M | |
| Cash Acquisitions | $1.5B | -$1.1B | -$10.5B | $523M | $6M | |
| Cash From Investing | $818M | -$1.4B | -$11.2B | -$107M | -$417M | |
| Dividends Paid (Ex Special Dividend) | -$297M | -$299M | -$300M | -$306M | -$233M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.3B | $11.6B | $3.4B | $3.5B | |
| Long-Term Debt Repaid | -$742M | -$792M | -$826M | -$4.7B | -$4.2B | |
| Repurchase of Common Stock | -$750M | -$750M | -- | -- | -- | |
| Other Financing Activities | -$50M | -$193M | -$127M | -$65M | -$111M | |
| Cash From Financing | -$1.8B | -$766M | $10.3B | -$1.6B | -$1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $192M | -$175M | $553M | $343M | -$524M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $863M | $1.4B | $837M | $1.6B | $502M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $323M | $504M | $93M | $124M | -$17M | |
| Depreciation & Amoritzation | $91M | $106M | $178M | $227M | $191M | |
| Stock-Based Compensation | $12M | $15M | $14M | $10M | $5M | |
| Change in Accounts Receivable | -$184M | -$240M | -$216M | -$55M | -$99M | |
| Change in Inventories | -$62M | -$32M | $45M | -$19M | $14M | |
| Cash From Operations | $116M | $316M | -$96M | $101M | $37M | |
| Capital Expenditures | $92M | $137M | $164M | $137M | $102M | |
| Cash Acquisitions | -- | -- | $9M | -- | $6M | |
| Cash From Investing | $98M | -$149M | -$178M | -$151M | -$98M | |
| Dividends Paid (Ex Special Dividend) | -$78M | -$73M | -$76M | -$77M | -$3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $74M | $338M | $267M | $3.3B | |
| Long-Term Debt Repaid | -$7M | -$7M | -$307M | -$424M | -$3.2B | |
| Repurchase of Common Stock | -$267M | -$17M | -- | -- | -- | |
| Other Financing Activities | -$21M | -$72M | -$24M | -$26M | -$78M | |
| Cash From Financing | -$371M | -$95M | -$69M | -$259M | $45M | |
| Beginning Cash (CF) | $955M | $536M | $1.5B | $1.8B | $962M | |
| Foreign Exchange Rate Adjustment | -$7M | -$3M | $2M | -$13M | $5M | |
| Additions / Reductions | -$157M | $72M | -$343M | -$309M | -$16M | |
| Ending Cash (CF) | $791M | $605M | $1.2B | $1.5B | $951M | |
| Levered Free Cash Flow | $24M | $179M | -$260M | -$36M | -$65M | |
Get CE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CE
Sector
P/E ratio
7.03x
16.29x
PEG ratio
0.14x
0.00x
P/B ratio
1.20x
1.42x
Price / LTM sales
0.62x
1.42x
Growth Metrics
CE
Sector
Revenue growth
-8.5%
1.07%
Earnings growth
-87.8%
--
Revenue (5-year growth)
10.3%
3.71%
Earnings forecast
$1.40
$0.04
Profitability
CE
Sector
Profitability FY 2024
$2.4B
--
Return on invested capital
-8.42%
1.75%
Return on assets
-6.72%
1.06%
Return on equity
-24.41%
2.52%
Earnings Date
Last Earnings Date
May
5
Next Earnings Date
Aug
11
Estimated Next Earnings Date
Aug
4
Balance Sheet
CE
Sector
Total cash
$951M
$2.4M
Short term investments
--
$326.7K
Total assets
$22.9B
$21.1M
Long term debt
$12.8B
$74M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
